血清甲胎蛋白、γ-谷氨酰转肽酶Ⅱ、高尔基体蛋白73检测在原发性肝癌早期诊断中的价值

朱陈; 孙源源; 金燕

doi:10.3969/j.issn.1001-5256.2014.10.022

血清甲胎蛋白、γ-谷氨酰转肽酶Ⅱ、高尔基体蛋白73检测在原发性肝癌早期诊断中的价值

DOI: 10.3969/j.issn.1001-5256.2014.10.022

江苏省南通市第三人民医院消化内科

详细信息

中图分类号: R735.7
计量
- 文章访问数: 2753
- HTML全文浏览量: 15
- PDF下载量: 620
- 被引次数: 0
出版历程
- 收稿日期: 2014-06-16
- 出版日期: 2014-10-20

Values of serum AFP, GGTⅡ and GP73 in diagnosis of primary hepatocellular carcinoma

Department of Gastroenterology, Nantong 3rd Peoples' Hospital

摘要

摘要:
目的探讨血清甲胎蛋白（AFP）、γ-谷氨酰转肽酶（GGT）Ⅱ、高尔基体蛋白73（GP73）对于原发性肝癌患者的早期诊断价值。方法抽取2013年2月至2014年2月在南通市第三人民医院进行治疗的100例肝病患者（50例肝炎及肝硬化患者为肝脏良性病变组,50例原发性肝癌患者为原发性肝癌组）和50例正常体检者血清,分别利用电化学发光法、特异免疫膜吸附法、酶联免疫吸附法检测血清中的AFP、GGTⅡ、GP73水平。计量资料多组间比较采用方差分析,两两比较采用q检验;对单项及联合检测结果作图绘成受试者工作特征曲线（ROC曲线）,计算曲线下面积（AUC）,观察AFP、GGTⅡ、GP73单独和联合检测的AUC、敏感度、特异度。结果血清GGTⅡ水平在对照组或肝脏良性病变组、原发性肝癌组的两两比较中差异均有统计学意义（P值均<0.05）,但是对照组与肝脏良性病变组差异没有统计学意义（p值均>0.05）。AFP和GP73水平在原发性肝癌组、肝脏良性病变组,对照组的两两比较中差异均有统计学意义（P值均<0.05）。单独检测时GP73的特异度为69%,敏感度为92%;GGTⅡ的特异度为64%,...
- 肝肿瘤 /
- 早期诊断 /
- 甲胎蛋白类 /
- γ-谷氨酰转移酶 /
- 高尔基体蛋白73
Abstract:
Objective To explore the early diagnostic values of serum alpha-fetoprotein ( AFP) , gamma-glutamyltransferase Ⅱ ( GGTⅡ) , and Golgi protein 73 ( GP73) in patients with primary hepatocellular carcinoma ( PHC) . Methods The serum specimens of 100 patients with liver diseases ( 50 cases of hepatitis and liver cirrhosis and 50 cases of PHC) and 50 healthy people were collected in our hospital from February 2013 to February 2014. Electrochemical luminescence technique, specific immuno-membrane adsorption assay, and enzyme-linked immunosorbent assay were used to measure the serum levels of AFP, GGTⅡ, and GP73. Comparison of continuous data between multiple groups was made by analysis of variance, and comparison between two groups was made by q test. The receiver operating characteristic ( ROC) curves of single or combined test results were made, and the areas under the ROC curves ( AUCs) were calculated. The sensitivity, specificity, and AUCs of AFP, GGTⅡ, GP73, and the combined test were analyzed and compared. Results The level of serum GGTⅡ in the PHC group was significantly different compared with those in the other two groups ( F = 16. 224, P < 0. 05) , but there was no significant difference between the normal group and the hepatitis and liver cirrhosis group ( P > 0. 05) . Significant differences in serum levels of AFP and GP73 were observed by paired comparison between the PHC group, hepatitis and liver cirrhosis group, and normal group ( F =193. 128, F = 20. 231, P < 0. 05 for both) . When assayed alone, the specificities of GP73, GGTⅡ, and AFP were 69%, 64% and 51%, respectively, and the sensitivities were 92%, 84%, and 76%, respectively. In combined test, the specificity was 94. 6% and the sensitivity was 98. 8%. Conclusion The GP73 test is the best performer in the single assays. Combined test of serum AFP, GGTⅡ, and GP73 shows a good diagnostic value for PHC with greatly improved specificity and sensitivity.
- liver neoplasms /
- early diagnosis /
- alpha-fetoproteins /
- gamma-glutamyltransferase /
- golgi protein 73

HTML全文

参考文献(13)

[1]MEGURO M, MIZUGUCHI T, KAWAMOTO M, et al.The molecular patho genesis and clinical implications of hepatoeellular carcinoma[J].Int J Hepatd, 2011, 2011:818672.

[2]CHEN Z.The third cause of death review sampling survey report[M].Beijing:Chinese Peking Union Medical College Press, 2008:18-45. (in Chinese) 陈竺.全国第三次死因回顾抽样调查报告[M].北京:中国协和医科大学出版社, 2008:18-45.

[3]YAO DF, DONG ZZ, YAO M.Specific molecular markers in hepatocellularcarcinomal[J].Hepatobiliary Pancreat Dis Int, 2007, 6 (3) :241-247.

[4]CHEN SZ.The correlation analysis of AFP levels and serum HBV markers and HBV-DNA in primary liver cancer[J].Proceeding Clin Med, 2012, 38 (1) :209-210. (in Chinese) 陈素珍.原发性肝癌患者血清HBV标志物和HBV-DNA与其AFP水平的相关生物分析[J]临床医药实践, 2012, 38 (1) :209-210.

[5]NIE RH, LIU YY.Application of detection of tumor markers AFP, CA125, CA199 and CEA in diagnosis and treatment for patients with hepatitis and liver cirrhosis[J].J Jilin Univ:Medicine Edition, 2012, 38 (1) :119-122. (in Chinese) 聂荣慧, 刘元元.肿瘤标志物AFP、CA125、CA199和CEA检测在肝炎、肝硬化患者诊断和治疗中的应用[J].吉林大学学报:医学版, 2012, 38 (1) :119-122.

[6]SHI L, WU LL, LIN XY, et al.Clinical value of diagnostic indicators in serum of chronic hepatitis[J].Chin J Nosocomiol, 2011, 21 (1) :73-74. (in Chinese) 石亮, 伍丽丽, 林向阳, 等.慢性肝病患者血清中的诊断指标临床意义探讨[J].中华医院感染学杂志, 2011, 21 (1) :73-74.

[7]XU WS, LIU YF, FAN H, et al.Clinical value of combined Alpha fetoprotein with C-reactive protein in the diagnosis of primary hepatic carcinoma[J].J Clin Hepatol, 2011, 27 (10) :1055-1057. (in Chinese) 徐伟松, 刘玉峰, 范辉, 等.联合检测AFP、C-反应蛋白在原发性肝癌诊断中的临床意义[J].临床肝胆病杂志, 2011, 27 (10) :1055-1057.

[8]HUANG YQ, CHEN QK.The incidence of liver cirrhosis cholelith disease and its effects on liver function[J].Guangzhou Med J, 1998, 29 (2) :471-472. (in Chinese) 黄越前, 陈其奎.肝硬化胆石症的发生率及其对肝功能的影响[J].广州医药, 1998, 29 (2) :471-472.

[9]MA H, ZHANG L, TANG B, et al.γ-Glutamyltranspeptidase is a prognostic marker of survival and recurrence in radiofrequency-ablation treatment of hepatocellular carcinoma[J].Ann Surg Oncol, 2014, 21 (9) :3084-3089.

[10]KLADNEY RD, BULLA GA, GUO L, et al.GP73, a novel Golgi-lo-calized protein upregulated by viral infection[J].Gene, 2000, 249 (1-2) :53-65.

[11]BACHERT C, FIMMEL C, LINSTEDT AD.Endosomal trafficking and proprotein convease cleavage of cis Golgi protein GP73 produces markerfor hepatocellular[J].Traffic, 2007, 8 (10) :1415-1423.

[12]SUN YL, YANG HY, MAO YL, et al.Increased Golgi protein73 expressing in hepatocellular carcinoma tissue correlates with tumoraggression but not smwival[J].J Gastroenterol Hepatol, 2011, 26 (7) :1207-1212.

[13]BAO YX, YANG Y, ZHAO HR, et al.Clinical significance and diagnostic value of Golgi-protein 73 in patients with early-stage primary hepatocellular carcinoma[J].Chin J Oncol, 2013, 35 (7) :505-508.包永星, 杨颖, 赵化荣, 等.高尔基体蛋白73对早期肝癌的诊断价值及临床意义[J].中华肿瘤杂志, 2013, 35 (7) :505-508.

施引文献

资源附件(0)

访问统计